BioSpace News Archive

Drug Development

The New England Journal of Medicine Publishes Data from Dendreon Corporation’s Pivotal Phase 3 PROVENGE IMPACT Study

July 29, 2010
·
6 min read
Business

Hill-Rom, Inc. Reports 80 Percent Growth in Adjusted Earnings Per Share for Third Quarter

July 29, 2010
·
8 min read
Business

Micromet to Report Second Quarter 2010 Financial Results on August 5

July 29, 2010
·
1 min read
Drug Development

Anadys Pharmaceuticals, Inc.: ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24

July 29, 2010
·
7 min read
Business

Celldex Therapeutics, Inc. to Report Second Quarter 2010 Financial Results on August 4, 2010

July 29, 2010
·
1 min read
Business

Trinity Biotech Announces Quarter 2 Financial Results

July 29, 2010
·
17 min read
Drug Development

Anthera Pharmaceuticals, Inc. Initiates Expanded and Extended PEARL-SC Phase 2b Clinical Study in Lupus With A-623 - A Subcutaneous Dual Inhibitor of Membrane and Soluble B-Cell Activating Factor (BAFF or BLyS)

July 29, 2010
·
4 min read
Business

Arrayit Corporation Taps Former IVAX Diagnostics, Inc. Executive to Build Strategic Partnerships

July 29, 2010
·
1 min read
Business

Champions Biotechnology, Inc. Reports Fiscal 2010 Full-Year Financial Results

July 29, 2010
·
6 min read
Biotech Bay

Questcor Pharmaceuticals, Inc. (Headquarters) to Participate in Upcoming Conferences

July 29, 2010
·
1 min read